FDA Pushes Back AdComm Meetings, Including One to Discuss First OTC Birth Control Pill in U.S.

The FDA is pushing off or rescheduling several advisory committee meetings this week — including one to consider what could become of the first over-the-counter (OTC) daily oral contraceptive in the U.S., Opill.
Source: Drug Industry Daily